du Buf-Vereijken PW - Search Results

1

Skin vasomotor reflexes during inspiratory gasp: standardization by spirometric control does not improve reproducibility.

du Buf-Vereijken PW, Netten PM, Wollersheim H, Festen J, Thien T. du Buf-Vereijken PW, et al. Int J Microcirc Clin Exp. 1997 Mar-Apr;17(2):86-92. doi: 10.1159/000179212. Int J Microcirc Clin Exp. 1997. PMID: 9253686 Clinical Trial.

2

Urinary excretion of beta2-microglobulin and IgG predict prognosis in idiopathic membranous nephropathy: a validation study.

Branten AJ, du Buf-Vereijken PW, Klasen IS, Bosch FH, Feith GW, Hollander DA, Wetzels JF. Branten AJ, et al. J Am Soc Nephrol. 2005 Jan;16(1):169-74. doi: 10.1681/ASN.2004040287. Epub 2004 Nov 24. J Am Soc Nephrol. 2005. PMID: 15563570

3

Partial renal vein thrombosis in a kidney transplant: management by streptokinase and heparin.

du Buf-Vereijken PW, Hilbrands LB, Wetzels JF. du Buf-Vereijken PW, et al. Nephrol Dial Transplant. 1998 Feb;13(2):499-502. doi: 10.1093/oxfordjournals.ndt.a027857. Nephrol Dial Transplant. 1998. PMID: 9509473 No abstract available.

4

Swelling of hand and forearm caused by Mycobacterium bovis.

du Buf-Vereijken PW, van der Ven AJ, Meis JF, Lemmens JA, van der Meer JW. du Buf-Vereijken PW, et al. Neth J Med. 1999 Feb;54(2):70-2. doi: 10.1016/s0300-2977(98)00126-0. Neth J Med. 1999. PMID: 10079681

5

Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.

du Buf-Vereijken PW, Branten AJ, Wetzels JF; Membranous Nephropathy Study Group. du Buf-Vereijken PW, et al. Nephrol Dial Transplant. 2004 May;19(5):1142-8. doi: 10.1093/ndt/gfh036. Epub 2004 Feb 19. Nephrol Dial Transplant. 2004. PMID: 14993502 Clinical Trial.

6

Restrictive use of immunosuppressive treatment in patients with idiopathic membranous nephropathy: high renal survival in a large patient cohort.

du Buf-Vereijken PW, Feith GW, Hollander D, Gerlag PG, Wirtz JJ, Noordzij TC, Wetzels JF; Membranous Nephropathy Study Group. du Buf-Vereijken PW, et al. QJM. 2004 Jun;97(6):353-60. doi: 10.1093/qjmed/hch059. QJM. 2004. PMID: 15152109

7

Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.

du Buf-Vereijken PW, Wetzels JF. du Buf-Vereijken PW, et al. Nephrol Dial Transplant. 2004 Aug;19(8):2036-43. doi: 10.1093/ndt/gfh312. Epub 2004 Jun 8. Nephrol Dial Transplant. 2004. PMID: 15187191

8

du Buf-Vereijken PW, Wetzels JF. du Buf-Vereijken PW, et al. Nephrol Dial Transplant. 2006 Feb;21(2):389-96. doi: 10.1093/ndt/gfi219. Epub 2005 Oct 18. Nephrol Dial Transplant. 2006. PMID: 16234291

9

Idiopathic membranous nephropathy: outline and rationale of a treatment strategy.

du Buf-Vereijken PW, Branten AJ, Wetzels JF. du Buf-Vereijken PW, et al. Am J Kidney Dis. 2005 Dec;46(6):1012-29. doi: 10.1053/j.ajkd.2005.08.020. Am J Kidney Dis. 2005. PMID: 16310567 Review.

10

Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: a randomized controlled trial.

Hofstra JM, Branten AJ, Wirtz JJ, Noordzij TC, du Buf-Vereijken PW, Wetzels JF. Hofstra JM, et al. Nephrol Dial Transplant. 2010 Jan;25(1):129-36. doi: 10.1093/ndt/gfp390. Epub 2009 Aug 8. Nephrol Dial Transplant. 2010. PMID: 19666912 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters